Amplia Therapeutics Ltd.ASX: ATX

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Amplia Therapeutics Ltd. via ASX

Filed with ASX ·

28 Oct ober 2026 ASX RELEASE QUARTERLY ACTIVITIES AND CASH FLOW REPORTS – September 2026 Key Highlights from the Quarter • The ACCENT trial in pancreatic cancer nears completion with promising data continuing to be recorded • A collaboration with Eli Lilly, the world’s largest...

View Attachment

6ix is reading this filing.

Amplia Therapeutics Ltd. on 6ix

Earlier from Amplia Therapeutics

All Amplia Therapeutics news releases